BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.63B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$337M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$172M |
| 4 |
PPG Industries
PPG
|
+$132M |
| 5 |
AGN
Allergan plc
AGN
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$750M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$525M |
| 3 |
Apple
AAPL
|
+$317M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$275M |
| 5 |
McDonald's
MCD
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.55% |
| 2 | Financials | 8.18% |
| 3 | Healthcare | 5.72% |
| 4 | Consumer Discretionary | 5.19% |
| 5 | Communication Services | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDR
1251
DELISTED
McDermott International
MDR
| $546K | ﹤0.01% |
42,310
-15,999
| -27% | -$220K |
|
1252
C.H. Robinson
CHRW
$17.1B
| $540K | ﹤0.01% |
7,960
-41,442
| -84% | -$2.78M |
|
|
CNW
1253
DELISTED
CON-WAY INC.
CNW
| $538K | ﹤0.01% |
11,343
+6,976
| +160% | +$273K |
|
1254
Western Alliance Bancorporation
WAL
$8.92B
| $536K | ﹤0.01% |
17,467
+10,990
| +170% | +$355K |
|
1255
Comstock Resources
CRK
$4.09B
| $536K | ﹤0.01% |
56,119
-149,003
| -73% | -$1.65M |
|
1256
EnerSys
ENS
$6.81B
| $534K | ﹤0.01% |
9,975
+5,380
| +117% | +$310K |
|
1257
Avnet
AVT
$7.87B
| $534K | ﹤0.01% |
12,519
-31,968
| -72% | -$1.33M |
|
|
FMER
1258
DELISTED
FIRSTMERIT CORP
FMER
| $534K | ﹤0.01% |
30,234
+17,676
| +141% | +$332K |
|
|
ISIL
1259
DELISTED
Intersil Corp
ISIL
| $534K | ﹤0.01% |
45,661
-25,162
| -36% | -$280K |
|
1260
Acadia Pharmaceuticals
ACAD
$5.07B
| $534K | ﹤0.01% |
16,139
+9,508
| +143% | +$396K |
|
|
VRNT
1261
DELISTED
Verint Systems
VRNT
| $533K | ﹤0.01% |
24,225
+14,206
| +142% | +$393K |
|
1262
Blackbaud
BLKB
$2.1B
| $532K | ﹤0.01% |
9,475
+5,575
| +143% | +$326K |
|
1263
Chemed
CHE
$7.02B
| $531K | ﹤0.01% |
3,975
+2,108
| +113% | +$295K |
|
1264
Dycom Industries
DY
$12.3B
| $530K | ﹤0.01% |
7,327
-42,711
| -85% | -$2.96M |
|
1265
Genesco
GCO
$391M
| $529K | ﹤0.01% |
9,271
+1,183
| +15% | +$73.5K |
|
1266
United Bankshares
UBSI
$6.66B
| $529K | ﹤0.01% |
13,926
+8,149
| +141% | +$320K |
|
1267
Helen of Troy
HELE
$696M
| $529K | ﹤0.01% |
5,920
+3,153
| +114% | +$283K |
|
|
AAN.A
1268
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $528K | ﹤0.01% |
14,630
-20,331
| -58% | -$734K |
|
1269
Arrow Electronics
ARW
$10.6B
| $528K | ﹤0.01% |
9,550
-25,282
| -73% | -$1.4M |
|
1270
World Kinect Corp
WKC
$1.89B
| $527K | ﹤0.01% |
14,710
+13,891
| +1,696% | +$578K |
|
|
CYT
1271
DELISTED
CYTEC INDS INC
CYT
| $527K | ﹤0.01% |
7,130
+4,658
| +188% | +$325K |
|
1272
Woodward
WWD
$21.4B
| $526K | ﹤0.01% |
12,912
-35,308
| -73% | -$1.67M |
|
1273
OGE Energy
OGE
$9.69B
| $525K | ﹤0.01% |
19,200
+18,002
| +1,503% | +$513K |
|
1274
PTC
PTC
$16.1B
| $523K | ﹤0.01% |
16,480
+14,547
| +753% | +$520K |
|
|
IPXL
1275
DELISTED
Impax Laboratories, Inc.
IPXL
| $522K | ﹤0.01% |
14,812
+8,847
| +148% | +$399K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2015 Portfolio in Review
As of Q3 2015, BNP Paribas Financial Markets held 3,791 positions worth $39.9B, up 11% from $35.8B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
BNP Paribas Financial Markets deployed $7.43B of net new capital in Q3 2015, opening 248 new positions and adding to 2,429 existing holdings. Its largest new stake was Allergan plc: 397,434 shares worth $108M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 10% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $525M trimmed.
- BNP Paribas Financial Markets's largest Q3 2015 buy was Allergan plc: 397,434 shares worth $108M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $5.63B increase.
- BNP Paribas Financial Markets's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $525M.
- BNP Paribas Financial Markets fully exited Canadian National Railway in Q3 2015, selling an estimated $750M.
- BNP Paribas Financial Markets's ten largest holdings make up 45% of its $39.9B portfolio in Q3 2015.
- BNP Paribas Financial Markets opened 248 new positions and closed 172 in Q3 2015.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $39.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2015, filed 13 Nov 2015.